Rickets
Also known as: Rachitis
Methodology & AI Transparency ⓘ
Rickets Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Rickets causes soft, weak bones in children.
- 2 Real-world patient consensus: Mapped to Osteoporosis, Vitamin D & Bone Density under ICD-10-CM E55.0 for Rickets clinical workups.
- 3 Typical cash cost range: Primary evaluation for Rickets incorporates secondary metabolic bone in Rickets (E55.0: lab panel (25-OH-D) and symptom diary review.
- 4 Top reported side effects / signs: Key Bone Density biomarkers for Rickets (E55.0): Serum Calcium, Phosphorus in Rickets (E55.0: & PTH) & CTX / P1NP in Rickets (E55.0: Bone Turnover Markers) (Balanced remodeling on therapy (E55.0)).
Ask our AI Specialists anything about Rickets
What Is Rickets?
Rickets causes soft, weak bones in children. It usually occurs when they do not get enough vitamin D , which helps growing bones absorb the minerals calcium and phosphorous. It can also happen when calcium or phosphorus levels are too low. Your child might not get enough vitamin D if he or she: Has dark skin Spends too little time outside Has on sunscreen all the time when out of doors Doesn't eat foods containing vitamin D because of lactose intolerance or a strict vegetarian diet Is breastfed without receiving vitamin D supplements Can't make or use vitamin D because of a medical disorder such as celiac disease In addition to dietary rickets, children can get an inherit.
Pathophysiology, Underlying Causes & Clinical Presentation
Biological expression of Rickets (E55.0, Bone Density) reflects uncoupled skeletal remodeling in Rickets (E55.0: where osteoclast-mediated bone). Cross-referenced with NIH MeSH (Rickets, Rickets, Hypophosphatemic), longitudinal control is benchmarked via Serum Calcium, Phosphorus in Rickets (E55.0: & PTH).
Common Symptoms & Clinical Signs
- • Spends too little time outside
- • Has on sunscreen all the time when out of doors
- • Presentation of Rickets (E55.0): gradual loss of in Rickets (E55.0: standing height)
- • Secondary Rickets clinical sign: diffuse bone aching in Rickets (E55.0: or muscle weakness)
Primary Federal Reference: NIH / National Library of Medicine MedlinePlus Entry ↗
Rickets Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | E55.0 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | Osteoporosis, Vitamin D & Bone Density | NIH MedlinePlus Health Topics |
| Diagnostic / Lab Marker: Serum Calcium, Phosphorus in Rickets (E55.0: & PTH) | Ca 8.9–10.1 mg/dL; PTH 15–65 pg/mL (E55.0) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: CTX / P1NP in Rickets (E55.0: Bone Turnover Markers) | Balanced remodeling on therapy (E55.0) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: DEXA Bone Mineral in Rickets (E55.0: Density T-Score) | > -1.0 (hip & lumbar spine) (E55.0) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Rickets
Treatment selection for Rickets depends on clinical severity, diagnostic lab results, and medical history. Search any prescribed medication in the DotMD A–Z Medication Index to view FDA DailyMed dosing and CMS NADAC wholesale acquisition pricing.
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Rickets)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| New Insights on Population how the body absorbs the medicine/how the medicine works in the body: What a 420-Participant Study Found A population PK/PD model was developed in Chinese healthy male subjects and postmenopausal osteoporotic women. British journal of clinical pharmacology • 2026-02-15 • Phase III Randomized Trial | N = 420 | 87/100 | PMID 40974130 ↗ |
| What the Latest Evidence Really Says About Comparative real-world benefits and safety among high-intensity statins. Conclusion: This review further confirms that high-intensity statins reduce LDL by ≥50%, favoring rosuvastatin over atorvastatin. Journal of comparative effectiveness research • 2023-03-15 • Meta-Analysis | Multi-cohort | 86/100 | PMID 36847307 ↗ |
| Can This Approach Help? Inside the Latest Research on Item Response Theory Quantifies the Relationship Between Improvements in Serum The analyses confirmed the importance of prolonged serum phosphate level correction in adult patients with XLH. Clinical pharmacology and therapeutics • 2024-11-15 • Phase III Randomized Trial | Multi-cohort | 82/100 | PMID 39129452 ↗ |
| Can This Approach Help? Inside the Latest Research on Complications of orthopedic treatment in patients diagnosed with X-linked In average, one complication occurred per surgery and the severity of complications were substantial. Journal of pediatric endocrinology & metabolism : JPEM • 2022-08-26 • Phase III Randomized Trial | N = 79 | 82/100 | PMID 35700440 ↗ |
| Can This Approach Help? Inside the Latest Research on Effect of Filgotinib on the how the body absorbs the medicine of Atorvastatin, Rosuvastatin exposure was moderately higher with filgotinib getting both at the same time-GLSM ratios (90% CI), 1.68 (1.43-1.97) for C max ; 1.42 (1.30-1.57) for AUC inf -but this was not considered clinically relevant. Clinical pharmacology in drug development • 2022-02-15 • Randomized Controlled Trial | N = 27 | 82/100 | PMID 34468080 ↗ |
Rickets Patient Community & “People Like Me” Threads
Filter Rickets community threads and patient logs by age, biological sex, dosage, and treatment duration.